CDR-Life is a leader in therapeutic antibody fragments. Based on the companies' proprietary technology platform for making cancer-targeted immunotherapies, it has several game-changing therapy candidates against blood and solid tumor cancers.

Products, services, technology

CDR-Life is developing a diversified portfolio of next generation therapies against cancers and eye disease.

Cooperation possibilities

CDR-Life is looking to partner with companies and investors that want to help change the game for cancer patients.

Location
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2017
  • Number of employees in Switzerland
    10-19
Key business